Literature DB >> 24810993

High R.E.N.A.L. Nephrometry scores are associated with pathologic upstaging of clinical T1 renal-cell carcinomas in radical nephrectomy specimens: implications for nephron-sparing surgery.

Melissa H W Tay1, Thomas P Thamboo, Fiona M W Wu, Chen Zhaojin, Tai Bee Choo, Lata Ramaan, Ho Yee Tiong.   

Abstract

BACKGROUND AND
PURPOSE: The R.E.N.A.L. Nephrometry Score (RNS) was developed to standardize the reporting of anatomic information of a renal mass. This study aimed to identify the association of preoperative clinical and tumor features assessed by the RNS with pathologic upstaging of clinical T1 renal-cell carcinomas (RCCs) in complete en bloc radical nephrectomy (RN) specimens. PATIENTS AND METHODS: A review was performed for 65 consecutive patients (2005-2013) who underwent RNs for a unilateral clinical T1N0M0 RCC. The RNS was measured in all patients based on preoperative CT scans. Pathologic review was performed to identify patients with final pathologic upstaging. Associations were assessed with the Fisher exact test, Student t test, and Wilcoxon rank sum test.
RESULTS: Of the 65 patients (41 male, mean age 59 years), 4 (6%) patients were upstaged to pT2 and 16 (25%) were upstaged to pT3a and above in the final histologic evaluation. Upstaged patients were not significantly different from those without in terms of age, sex, race, surgical approach, side of surgery, Fuhrman grade, and histologic cell type. Independent tumor features associated with pathologic upstaging were (R) tumor diameter (P=0.021), and (L) central location within polar lines (P=0.010). Tumors that were upstaged had a higher median total RNS than those without (10 vs 9, P=0.010). Complex tumors, with RNS≥10, were associated with significantly increased risk of upstaging compared with low and intermediate complexity categories (RNS<10) (relative risk=2.56, 95% confidence interval 1.22-5.37, P=0.014).
CONCLUSIONS: A higher RNS was associated with an increased risk of upstaging in clinical T1 cancers, predominantly from perinephric or sinus fat invasion in RN pathologic specimens. This may have implications on the selection of surgical option for the clinical T1 renal mass.

Entities:  

Mesh:

Year:  2014        PMID: 24810993     DOI: 10.1089/end.2014.0123

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  13 in total

1.  Renal cancer at unenhanced CT: imaging features, detection rates, and outcomes.

Authors:  Stacy D O'Connor; Stuart G Silverman; Laila R Cochon; Ramin K Khorasani
Journal:  Abdom Radiol (NY)       Date:  2018-07

2.  Nephrometry score correlated with tumor proliferative activity inT1 clear cell renal cell carcinoma-the tiger in the tall grasses versus the cat in plain sight.

Authors:  Ziting Wang; Ho Yee Tiong
Journal:  Ann Transl Med       Date:  2019-07

3.  [Risk factors of renal sinus invasion in clinical T1 renal cell carcinoma patients undergoing nephrectomy].

Authors:  Z H Sun; X J Huang; J H Dong; Z Liu; Y Yan; C Liu; L L Ma
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2021-08-18

4.  Survival Analysis of Pathological T3a Upstaging in Clinical T1 Renal Cell Carcinoma.

Authors:  Gu-Shun Lai; Jian-Ri Li; Shian-Shiang Wang; Chuan-Shu Chen; Chun-Kuang Yang; Sheng-Chun Hung; Chen-Li Cheng; Yen-Chuan Ou; Kun-Yuan Chiu
Journal:  In Vivo       Date:  2020 Mar-Apr       Impact factor: 2.155

5.  Pathological upstaging of clinical T1 renal cell carcinoma: an analysis of 115,835 patients from National Cancer Data Base, 2004-2013.

Authors:  Amanda Ghanie; Margaret K Formica; Dongliang Wang; Gennady Bratslavsky; Telisa Stewart
Journal:  Int Urol Nephrol       Date:  2017-12-15       Impact factor: 2.370

6.  Use of RENAL nephrometry scores for predicting tumor upgrading between core biopsies and surgical specimens: a prospective ex vivo study.

Authors:  Gui-Ming Zhang; Yao Zhu; Hua-Lei Gan; Hong-Kai Wang; Guo-Hai Shi; Hai-Liang Zhang; Bo Dai; Chao-Fu Wang; Ding-Wei Ye
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

7.  Pathological T3a Upstaging of Clinical T1 Renal Cell Carcinoma: Outcomes According to Surgical Technique and Predictors of Upstaging.

Authors:  Seung-Hwan Jeong; Jung Kwon Kim; Juhyun Park; Ho Joon Jeon; Min Young Yoon; Chang Wook Jeong; Ja Hyeon Ku; Hyeon Hoe Kim; Cheol Kwak
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240

8.  Factors associated with postoperative renal sinus invasion and perinephric fat invasion in renal cell cancer: treatment planning implications.

Authors:  Dong Ni; Xin Ma; Hong-Zhao Li; Yu Gao; Xin-Tao Li; Yu Zhang; Qing Ai; Qing-Bo Huang; Jun-Yao Duan; Xu Zhang
Journal:  Oncotarget       Date:  2017-12-15

9.  Outcomes of pathologic stage T3a renal cell carcinoma up-staged from small renal tumor: emphasis on partial nephrectomy.

Authors:  Hakmin Lee; Minseung Lee; Sang Eun Lee; Seok-Soo Byun; Hyeon Hoe Kim; Cheol Kwak; Sung Kyu Hong
Journal:  BMC Cancer       Date:  2018-04-16       Impact factor: 4.430

10.  Is surgeon intuition equivalent to models of operative complexity in determining the surgical approach for nephron sparing surgery?

Authors:  Pranav Sharma; Barrett Z McCormick; Kamran Zargar-Shoshtari; Wade J Sexton
Journal:  Indian J Urol       Date:  2016 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.